Clinical Trials Logo

Spinal Cord Astrocytoma clinical trials

View clinical trials related to Spinal Cord Astrocytoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT04211974 Recruiting - Clinical trials for Spinal Cord Astrocytoma

Genomic Landscape of Intramedullary Astrocytoma

GIMA
Start date: December 10, 2019
Phase:
Study type: Observational

intramedullary astrocytoma is a rare and devastating spinal cord glioma. while the management of intracranial astrocytoma includes gross total resection, radiotherapy and chemotherapy, spinal cord astrocytoma is very difficult to be totally removed due to its infiltrative nature and unclear plane of dissection; Moreover, the use radiotherapy and chemotherapy for spinal cord astrocytoma is controversial. Therefore, the treatment for spinal cord astrocytoma is very limited as compared to its intracranial counterpart. Inadequate understanding of spinal cord astrocytoma mainly contribute to limited treatment, while the molecular profiling of intracranial astrocytoma is relatively well understood. Hence, we performed whole-exome sequencing of intramedullary astrocytoma aiming to identify the pathophysiological mechanisms underlying spinal cord astrocytoma